iBio CDMO
iBio offers a full range of development and manufacturing services to move your projects from pre-clinical to market launch. Our FastPharming® System shortens your development timelines and provides for seamless scale-up. Our Glycaneering™ Technology affords greater control and can deliver increased product potency and quality. We offer a range of recombinant products including monoclonal antibodies, antigens for subunit vaccine design, lysosomal enzymes, and many more.
Advantages of our FastPharming technology include:
Speed— from gene sequence to protein production in as little as 3 weeks
Scalability—to increase production, we simply grow more plants
Environmental Sustainability—avoids the plastic waste of single-use bioprocessing systems
Safety— adventitious mammalian viruses can't grow in plants, minimizing contamination risks
Quality—batch-to-batch consistency with controlled processing conditions and protein engineering controls
Economy—avoids expensive, labor-intensive, and costly stable cell line development and clone selection, as well as costly bioreactor equipment
Glycaneering™—FastPharming delivers products with inherently greater N-linked glycosylation homogeneity compared to competing platforms. Glycaneering facilitates further control and tailoring of N-glycosylation
Versatility—ability to express a wide variety of recombinant proteins including monoclonal antibodies, blood factors and cytokines, lysosomal enzymes, vaccine antigens, and others...
More Info Less Info